Adrenal Insufficiency following Stereotactic Ablative Radiotherapy (SAbR) of Adrenal Gland Metastases.

Autor: Hamidi O; Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Miljanic M; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Tumyan G; Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Christie A; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Mirfakhraee S; Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Ali S; Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Dohopolski M; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Gottumukkala S; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Brugarolas J; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Timmerman R; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Hannan R; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Publikováno v: Cancers [Cancers (Basel)] 2024 Sep 12; Vol. 16 (18). Date of Electronic Publication: 2024 Sep 12.

Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC study.

Autor: Ferhanoglu B; Division of Hematology, Department of Internal Medicine, Koç University School of Medicine, Istanbul, Turkey., Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul National University Cancer Research Institute, Seoul, South Korea., Karduss A; Bone Marrow Transplant Program, Instituto de Cancerologia, Clínica las Américas, Medellín, Colombia., Brittain D; Albert Alberts Stem Cell Transplant Center, Pretoria East Hospital, Pretoria, South Africa., Tumyan G; Department of Chemotherapy of Hemoblastosis, Blokhin Russian Cancer Research Center, Moscow, Russia., Al-Mansour M; Adult Medical Oncology, Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs-Western Region, Jeddah, The Kingdom of Saudi Arabia.; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, The Kingdom of Saudi Arabia., Zerga M; Department of Hematology, Angel Roffo Institute, Buenos Aires, Argentina., Song Y; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital, Beijing, China., Rivas-Vera S; Department of Hematology, Instituto Nacional de Cancerologia Mexico, Mexico City, Mexico., Kwong YL; Bone Marrow Transplant Unit, Queen Mary Hospital, Hong Kong, China.; Hematology Division, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, University of Hong Kong, Hong Kong, China., Lim ST; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Yeh SP; Division of Hematology and Oncology, Department of Medicine, China Medical University Hospital, Taichung, Taiwan., Abdillah A; Takeda Pharmaceuticals International AG-Singapore Branch, Singapore, Singapore., Huang Z; Takeda R&D Data Sciences Institute, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA., Dalal M; Takeda R&D Data Sciences Institute, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA., Wan H; Takeda Pharmaceuticals International AG-Singapore Branch, Singapore, Singapore., Hertzberg M; Department of Clinical Haematology, Prince of Wales Hospital, Sydney, Australia.; University of New South Wales, Sydney, Australia.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (14), pp. 3317-3330. Date of Electronic Publication: 2022 Oct 06.

A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia.

Autor: Panayiotidis P; Laikon General Hospital and National and Kapodistrian University of Athens, Athens, Greece., Tumyan G; N.N. Blokhin Russian Cancer Research Centre, Moscow, Russian Federation., Thieblemont C; AP-HP, Hôpital Saint-Louis, and Université de Paris, Paris, France., Ptushkin VV; City Clinical Hospital Named After S.P. Botkin, Moscow, Russian Federation., Marin-Niebla A; Hospital Universitari Vall d'Hebron, Barcelona, Spain., García-Sanz R; Hospital Universitario de Salamanca (HUSA/IBSAL/CIBERONC), Salamanca, Spain., Le Gouill S; Service d'Hématologie Clinique du CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France., Stathis A; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland, and Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Bottos A; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Hamidi H; Genentech, Inc, South San Francisco, CA, USA., Katz P; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Perretti T; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Willis JC; Roche Products Ltd, Welwyn Garden City, UK., Buske C; CCC Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2022 May; Vol. 63 (5), pp. 1058-1069. Date of Electronic Publication: 2022 Jan 19.

Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study.

Autor: Kwak LW; Comprehensive Cancer Center, Duarte, CA 91010., Sancho JM; Hematology Department, The Catalan Institute of Oncology-The Josep Carreras Leukemia Research Institute, Hospital Germans Trias i Pujol, Carretera Canyet, Badalona, 08916, Spain., Cho SG; Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, 06591, South Korea., Nakazawa H; Department of Hematology, Shinshu University School of Medicine, Nagano 390-8621, Japan., Suzumiya J; Shimane University Hospital, Innovative Cancer Center/Oncology-Hematology, Izumo, Shimane 693-8501, Japan., Tumyan G; Division of Hematology and Bone Marrow Transplantation, N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Science, Moscow, 115478, Russia., Kim JS; Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, 03722, South Korea., Menne T; Northern Institute for Cancer Care, Newcastle University, NE7 7DN, UK., Mariz J; Department of Onco-Hematology, Portuguese Institute of Oncology, Rua Dr Antonio Bernardino de Almeida, Porto, 4200-072, Portugal., Ilyin N; Russian Research Center for Radiology and Surgical Technologies, Ministry of Health of the Russian Federation, p. Pesochny, 197758, Russia., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, 331-115 Kraków, Poland., Lopez Martinez A; Department of Hematology, Hospital Arnau de Vilanova, Valencia, Comunidad Valenciana, 46015, Spain., Samoilova O; Department of Hematology, Nizhniy Novgorod Region Clinical Hospital, Nizhniy Novgorod, 603126, Russia., Zhavrid E; N. N. Alexandrov Republican Scientific and Practical Centre of Oncology and Medical Radiology, Lesnoy, Minsk, 223040, Belarus., Yañez Ruiz E; Department of Internal Medicine, Oncology-Hematology Unit, School of Medicine, Universidad de la Frontera, Temuco, 4780000, Chile., Trneny M; Department of Medicine, Charles University, 128 08, Czech Republic., Popplewell L; Toni Stephenson Lymphoma Cancer Center and Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA 91010., Ogura M; Department of Hematology and Oncology, Kasugai Municipal Hospital, Aichi 486-8510, Japan., Kim WS; Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06355, South Korea., Lee SJ; Celltrion, Inc, Incheon, 22014, South Korea., Kim SH; Celltrion, Inc, Incheon, 22014, South Korea., Ahn KY; Celltrion, Inc, Incheon, 22014, South Korea., Buske C; Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm, University Hospital of Ulm, 89081 Ulm, Germany. Electronic address: christian.buske@uni-ulm.de.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Feb; Vol. 22 (2), pp. 89-97. Date of Electronic Publication: 2021 Aug 28.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.